Skip to main content

Advertisement

SpringerLink
Log in

Chronic kidney disease–associated pruritus: what is known and its application in children

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Chronic kidney disease–associated pruritus (CKD-aP) or uremic pruritus (UP) is a frequent symptom in patients with kidney failure receiving kidney replacement therapy. Severe chronic kidney disease–associated pruritus correlates with poor outcome in patients on dialysis. It is multifactorial in etiology and has a significant impact on quality of life. There is, however, limited data for children. This review summarizes current epidemiology, clinical characteristics, pruritus scoring systems, and available therapeutic options for pruritus in patients with chronic kidney disease and those receiving dialysis. Optimal care requires proper awareness of the severity of symptoms, the impact on quality of life, and the possible long-term outcomes. Optimizing dialysis prescription and correcting electrolyte abnormalities are important treatment targets. A wide range of therapeutic options is also available although none are well-studied in children. An earlier recognition of this debilitating symptom in children and treatment is imperative.

Graphical Abstract

A higher resolution version of the Graphical abstract is available as Supplementary information

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M (2021) Chronic kidney disease-associated pruritus. Toxins (Basel) 13:527. https://doi.org/10.3390/toxins13080527

    Article  CAS  PubMed  Google Scholar 

  2. Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK (2006) Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 21:3495–3505. https://doi.org/10.1093/ndt/gfl461

    Article  PubMed  Google Scholar 

  3. Rayner HC, Larkina M, Wang M, Graham-Brown M, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber BA, Tentori F, Robinson BM, Pisoni RL (2017) International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol 12:2000–2007. https://doi.org/10.2215/CJN.03280317

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shirazian S, Aina O, Park Y, Chowdhury N, Leger K, Hou L, Miyawaki N, Mathur VS (2017) Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis 10:11–26. https://doi.org/10.2147/IJNRD.S108045

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mettang T, Pauli-Magnus C, Alscher DM (2002) Uraemic pruritus–new perspectives and insights from recent trials. Nephrol Dial Transplant 17:1558–1563. https://doi.org/10.1093/ndt/17.9.1558

    Article  PubMed  Google Scholar 

  6. Wojtowicz-Prus E, Kilis-Pstrusinska K, Reich A, Zachwieja K, Miklaszewska M, Szczepanska M, Szepietowski JC (2016) Chronic kidney disease-associated pruritus in children. Acta Derm Venereol 96:938–942. https://doi.org/10.2340/00015555-2454

    Article  CAS  PubMed  Google Scholar 

  7. Senturk N, Ozkaya O, Aytekin S, Bek K, Acikgoz Y, Aydin F, Bek Y, Turanli AY (2008) Characteristics of pruritus in children on peritoneal dialysis. Nephron Clin Pract 109:c168-172. https://doi.org/10.1159/000145461

    Article  PubMed  Google Scholar 

  8. Wu HY, Peng YS, Chen HY, Tsai WC, Yang JY, Hsu SP, Pai MF, Lu HM, Chiang JF, Ko MJ, Wen SY, Chiu HC (2016) A comparison of uremic pruritus in patients receiving peritoneal dialysis and hemodialysis. Medicine (Baltimore) 95:e2935. https://doi.org/10.1097/MD.0000000000002935

    Article  CAS  PubMed  Google Scholar 

  9. Min JW, Kim SH, Kim YO, Jin DC, Song HC, Choi EJ, Kim YL, Kim YS, Kang SW, Kim NH, Yang CW, Kim YK (2016) Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis. Kidney Res Clin Pract 35:107–113. https://doi.org/10.1016/j.krcp.2016.02.002

    Article  PubMed  PubMed Central  Google Scholar 

  10. Schricker S, Weisshaar E, Kupfer J, Mettang T (2020) Prevalence of pruritus in a single cohort of long-term kidney transplant recipients. Acta Derm Venereol 100:adv00066. https://doi.org/10.2340/00015555-3421

    Article  PubMed  Google Scholar 

  11. Chen ZJ, Cao G, Tang WX, Lv XY, Huang SM, Qin W, Ping F, Ye T (2009) A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus. Clin Exp Dermatol 34:679–683. https://doi.org/10.1111/j.1365-2230.2008.03075.x

    Article  CAS  PubMed  Google Scholar 

  12. Ko MJ, Wu HY, Chen HY, Chiu YL, Hsu SP, Pai MF, Ju Y, Lai CF, Lu HM, Huang SC, Yang SY, Wen SY, Chiu HC, Hu FC, Peng YS, Jee SH (2013) Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study. PLoS One 8:e71404. https://doi.org/10.1371/journal.pone.0071404

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Weisshaar E, Weiss M, Passlick-Deetjen J, Tschulena U, Maleki K, Mettang T (2015) Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch–results from a representative cross-sectional study. BMC Nephrol 16:184. https://doi.org/10.1186/s12882-015-0177-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, Kondo D, Skatsume M, Maruyama S, Kazama JJ, Akazawa K, Gejyo F (2006) Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 69:1626–1632. https://doi.org/10.1038/sj.ki.5000251

    Article  CAS  PubMed  Google Scholar 

  15. Shirazian S, Kline M, Sakhiya V, Schanler M, Moledina D, Patel C, Hazzan A, Fishbane S (2013) Longitudinal predictors of uremic pruritus. J Ren Nutr 23:428–431. https://doi.org/10.1053/j.jrn.2013.08.002

    Article  PubMed  Google Scholar 

  16. Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G (2006) Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol 66:184–191. https://doi.org/10.5414/cnp66184

    Article  CAS  PubMed  Google Scholar 

  17. Hampers CL, Katz AI, Wilson RE, Merrill JP (1968) Disappearance of “uremic” itching after subtotal parathyroidectomy. N Engl J Med 279:695–697. https://doi.org/10.1056/NEJM196809262791307

    Article  CAS  PubMed  Google Scholar 

  18. Chou FF, Ho JC, Huang SC, Sheen-Chen SM (2000) A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 190:65–70. https://doi.org/10.1016/s1072-7515(99)00212-4

    Article  CAS  PubMed  Google Scholar 

  19. Cho YL, Liu HN, Huang TP, Tarng DC (1997) Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 36:538–543. https://doi.org/10.1016/s0190-9622(97)70240-8

    Article  CAS  PubMed  Google Scholar 

  20. Dashti-Khavidaki S, Khalili H, Vahedi SM, Lessan-Pezeshki M (2010) Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity. Saudi J Kidney Dis Transpl 21:641–645

    PubMed  Google Scholar 

  21. Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stulten C, van der Kuip H, Pauli-Magnus C, Raub U, Kuhlmann U, Mettang T (2006) The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 21:749–755. https://doi.org/10.1093/ndt/gfi204

    Article  CAS  PubMed  Google Scholar 

  22. Zhao JH, Zhu QS, Li YW, Wang LL (2021) Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: a cross-sectional study. PLoS One 16:e0245370. https://doi.org/10.1371/journal.pone.0245370

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR (2011) Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications. Nephrol Dial Transplant 26:3338–3344. https://doi.org/10.1093/ndt/gfr053

    Article  CAS  PubMed  Google Scholar 

  24. Creagan ET, Rowland KM Jr, Suman VJ, Kardinal CG, Marschke RF Jr, Marks RS, Maples WJ (1997) Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma. Am J Clin Oncol 20:490–492. https://doi.org/10.1097/00000421-199710000-00011

    Article  CAS  PubMed  Google Scholar 

  25. Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG (1996) Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 11:2031–2036. https://doi.org/10.1093/oxfordjournals.ndt.a027092

    Article  CAS  PubMed  Google Scholar 

  26. Wojtowicz-Prus E, Kilis-Pstrusinska K, Reich A, Zachwieja K, Miklaszewska M, Szczepanska M, Szepietowski JC (2015) Disturbed skin barrier in children with chronic kidney disease. Pediatr Nephrol 30:333–338. https://doi.org/10.1007/s00467-014-2932-2

    Article  PubMed  Google Scholar 

  27. Szepietowski JC, Reich A, Schwartz RA (2004) Uraemic xerosis. Nephrol Dial Transplant 19:2709–2712. https://doi.org/10.1093/ndt/gfh480

    Article  PubMed  Google Scholar 

  28. Kato A, Hamada M, Maruyama T, Maruyama Y, Hishida A (2000) Pruritus and hydration state of stratum corneum in hemodialysis patients. Am J Nephrol 20:437–442. https://doi.org/10.1159/000046196

    Article  CAS  PubMed  Google Scholar 

  29. Yoshida Y, Hirama A, Hashimoto K, Sato T, Yokota N, Saeki H, Kishida M, Nakamura H, Kanakubo A, Tsuruoka S (2021) Efficacy of a moisturizer for pruritus accompanied by xerosis in patients undergoing dialysis: a multicenter, open-label, randomized verification study. J Dermatol 48:1327–1335. https://doi.org/10.1111/1346-8138.15950

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Shimizu Y, Sonoda A, Nogi C, Ogushi Y, Kanda R, Yamaguchi S, Nohara N, Aoki T, Yamada K, Nakata J, Io H, Kurusu A, Hamada C, Horikoshi S, Tomino Y (2014) B-type (brain) natriuretic peptide and pruritus in hemodialysis patients. Int J Nephrol Renovasc Dis 7:329–335. https://doi.org/10.2147/IJNRD.S65929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Papoiu AD, Emerson NM, Patel TS, Kraft RA, Valdes-Rodriguez R, Nattkemper LA, Coghill RC, Yosipovitch G (2014) Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease. J Neurophysiol 112:1729–1738. https://doi.org/10.1152/jn.00827.2013

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zakrzewska-Pniewska B, Jedras M (2001) Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR). Neurophysiol Clin 31:181–193. https://doi.org/10.1016/s0987-7053(01)00257-x

    Article  CAS  PubMed  Google Scholar 

  33. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U (1990) Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 34:136–141

    CAS  PubMed  Google Scholar 

  34. Kim BS, Inan S, Stander S, Sciascia T, Szepietowski JC, Yosipovitch G (2022) Role of kappa-opioid and mu-opioid receptors in pruritus: peripheral and central itch circuits. Exp Dermatol 31:1900–1907. https://doi.org/10.1111/exd.14669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Wieczorek A, Krajewski P, Koziol-Galczynska M, Szepietowski JC (2020) Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus. J Eur Acad Dermatol Venereol 34:2368–2372. https://doi.org/10.1111/jdv.16360

    Article  CAS  PubMed  Google Scholar 

  36. Barke KE, Hough LB (1993) Opiates, mast cells and histamine release. Life Sci 53:1391–1399. https://doi.org/10.1016/0024-3205(93)90581-m

    Article  CAS  PubMed  Google Scholar 

  37. Schricker S, Kimmel M (2021) Unravelling the pathophysiology of chronic kidney disease-associated pruritus. Clin Kidney J 14(Suppl 3):i23–i31. https://doi.org/10.1093/ckj/sfab200

    Article  PubMed  PubMed Central  Google Scholar 

  38. Matsumoto M, Ichimaru K, Horie A (1985) Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol 23:285–288

    CAS  PubMed  Google Scholar 

  39. Dugas-Breit S, Schopf P, Dugas M, Schiffl H, Rueff F, Przybilla B (2005) Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges 3:343–347. https://doi.org/10.1111/j.1610-0387.2005.05706.x

    Article  PubMed  Google Scholar 

  40. Francos GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Goyal S, Burke JF Jr (1991) Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol 30:884–889. https://doi.org/10.1111/j.1365-4362.1991.tb04360.x

    Article  CAS  PubMed  Google Scholar 

  41. Moon SJ, Kim HJ, Cho SB, Lee SH, Choi HY, Park HC, Ha SK (2014) Epidermal proteinase-activated receptor-2 expression is increased in end-stage renal disease patients with pruritus: a pilot study. Electrolyte Blood Press 12:74–79. https://doi.org/10.5049/EBP.2014.12.2.74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Huang WH, Lin JH, Weng CH, Hsu CW, Yen TH (2016) Environmental NO2 and CO exposure: ignored factors associated with uremic pruritus in patients undergoing hemodialysis. Sci Rep 6:31168. https://doi.org/10.1038/srep31168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M, Grewal M, McGuire D, National Registry Investigators ITCH (2010) A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 5:1410–1419. https://doi.org/10.2215/CJN.00100110

    Article  PubMed  PubMed Central  Google Scholar 

  44. Silverberg NB, Singh A, Laude TA (2001) Cutaneous manifestations of chronic renal failure in children of color. Pediatr Dermatol 18:199–204. https://doi.org/10.1046/j.1525-1470.2001.018003199.x

    Article  CAS  PubMed  Google Scholar 

  45. Attia EA, Hassan SI, Youssef NM (2010) Cutaneous disorders in uremic patients on hemodialysis: an Egyptian case-controlled study. Int J Dermatol 49:1024–1030. https://doi.org/10.1111/j.1365-4632.2010.04466.x

    Article  PubMed  Google Scholar 

  46. Ramakrishnan K, Bond TC, Claxton A, Sood VC, Kootsikas M, Agnese W, Sibbel S (2013) Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. Int J Nephrol Renovasc Dis 7:1–12. https://doi.org/10.2147/IJNRD.S52985

    Article  PubMed  PubMed Central  Google Scholar 

  47. Keithi-Reddy SR, Patel TV, Armstrong AW, Singh AK (2007) Uremic pruritus. Kidney Int 72:373–377. https://doi.org/10.1038/sj.ki.5002197

    Article  CAS  PubMed  Google Scholar 

  48. Caffarelli C, Paravati F, El Hachem M, Duse M, Bergamini M, Simeone G, Barbagallo M, Bernardini R, Bottau P, Bugliaro F, Caimmi S, Chiera F, Crisafulli G, De Ranieri C, Di Mauro D, Diociaiuti A, Franceschini F, Gola M, Licari A, Liotti L, Mastrorilli C, Minasi D, Mori F, Neri I, Pantaleo A, Saretta F, Tesi CF, Corsello G, Marseglia GL, Villani A, Cardinale F (2019) Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr 45:101. https://doi.org/10.1186/s13052-019-0695-x

    Article  PubMed  PubMed Central  Google Scholar 

  49. Nowak DA, Yeung J (2017) Diagnosis and treatment of pruritus. Can Fam Physician 63:918–924

    PubMed  PubMed Central  Google Scholar 

  50. Reich A, Chatzigeorkidis E, Zeidler C, Osada N, Furue M, Takamori K, Ebata T, Augustin M, Szepietowski JC, Stander S (2017) Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol 97:759–760. https://doi.org/10.2340/00015555-2642

    Article  PubMed  Google Scholar 

  51. Evans JM, Glazer A, Lum R, Heale E, MacKinnon M, Blake PG, Walsh M (2020) Implementing a patient-reported outcome measure for hemodialysis patients in routine clinical care: perspectives of patients and providers on ESAS-r:Renal. Clin J Am Soc Nephrol 15:1299–1309. https://doi.org/10.2215/CJN.01840220

    Article  PubMed  PubMed Central  Google Scholar 

  52. Greenham L, Bennett PN, Dansie K, Viecelli AK, Jesudason S, Mister R, Smyth B, Westall P, Herzog S, Brown C, Handke W, Palmer SC, Caskey FJ, Couchoud C, Simes J, McDonald SP, Morton RL (2022) The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis. Trials 23:419. https://doi.org/10.1186/s13063-022-06355-0

    Article  PubMed  PubMed Central  Google Scholar 

  53. Altinok Ersoy N, Akyar I (2019) Multidimensional pruritus assessment in hemodialysis patients. BMC Nephrol 20:42. https://doi.org/10.1186/s12882-019-1234-0

    Article  PubMed  PubMed Central  Google Scholar 

  54. Balaskas E, Szepietowski JC, Bessis D, Ioannides D, Ponticelli C, Ghienne C, Taberly A, Dupuy P (2011) Randomized, double-blind study with glycerol and paraffin in uremic xerosis. Clin J Am Soc Nephrol 6:748–752. https://doi.org/10.2215/CJN.05490610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Okada K, Matsumoto K (2004) Effect of skin care with an emollient containing a high water content on mild uremic pruritus. Ther Apher Dial 8:419–422. https://doi.org/10.1111/j.1526-0968.2004.00175.x

    Article  PubMed  Google Scholar 

  56. Makhlough A, Ala S, Haj-Heydari Z, Kashi Z, Bari A (2010) Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. Iran J Kidney Dis 4:137–140

    PubMed  Google Scholar 

  57. Young TA, Patel TS, Camacho F, Clark A, Freedman BI, Kaur M, Fountain J, Williams LL, Yosipovitch G, Fleischer AB Jr (2009) A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatolog Treat 20:76–81. https://doi.org/10.1080/09546630802441218

    Article  CAS  PubMed  Google Scholar 

  58. Feily A, Dormanesh B, Ghorbani AR, Moosavi Z, Kouchak M, Cheraghian B, Mousavi SS, Mehrabian A, Ranjbari N (2012) Efficacy of topical cromolyn sodium 4% on pruritus in uremic nephrogenic patients: a randomized double-blind study in 60 patients. Int J Clin Pharmacol Ther 50:510–513. https://doi.org/10.5414/cp201629

    Article  CAS  PubMed  Google Scholar 

  59. Aquino TMO, Luchangco KAC, Sanchez EV, Verallo-Rowell VM (2020) A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus. Int J Dermatol 59:955–961. https://doi.org/10.1111/ijd.14953

    Article  CAS  PubMed  Google Scholar 

  60. Duque MI, Yosipovitch G, Fleischer AB Jr, Willard J, Freedman BI (2005) Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 52:519–521. https://doi.org/10.1016/j.jaad.2004.08.050

    Article  PubMed  Google Scholar 

  61. Rosner MH (2006) Cromolyn sodium: a potential therapy for uremic pruritus? Hemodial Int 10:189–192. https://doi.org/10.1111/j.1542-4758.2006.00093.x

    Article  PubMed  Google Scholar 

  62. Vessal G, Sagheb MM, Shilian S, Jafari P, Samani SM (2010) Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study. Nephrol Dial Transplant 25:1541–1547. https://doi.org/10.1093/ndt/gfp628

    Article  CAS  PubMed  Google Scholar 

  63. Mohammadi Kebar S, Sharghi A, Ghorghani M, Hoseininia S (2020) Comparison of gabapentin and hydroxyzine in the treatment of pruritus in patients on dialysis. Clin Exp Dermatol 45:866–871. https://doi.org/10.1111/ced.14270

    Article  CAS  PubMed  Google Scholar 

  64. Shohrati M, Davoudi SM, Keshavarz S, Sadr B, Tajik A (2007) Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan Ocul Toxicol 26:249–255. https://doi.org/10.1080/15569520701212340

    Article  CAS  PubMed  Google Scholar 

  65. Nakhaee S, Nasiri A, Waghei Y, Morshedi J (2015) Comparison of Avena sativa, vinegar, and hydroxyzine for uremic pruritus of hemodialysis patients: a crossover randomized clinical trial. Iran J Kidney Dis 9:316–322

    PubMed  Google Scholar 

  66. Nasrollahi AR, Miladipour A, Ghanei E, Yavari P, Haghverdi F (2007) Montelukast for treatment of refractory pruritus in patients on hemodialysis. Iran J Kidney Dis 1:73–77

    PubMed  Google Scholar 

  67. Mahmudpour M, Roozbeh J, Raiss Jalali GA, Pakfetrat M, Ezzat Zadegan S, Sagheb MM (2017) Therapeutic effect of montelukast for treatment of uremic pruritus in hemodialysis patients. Iran J Kidney Dis 11:50–55

    PubMed  Google Scholar 

  68. Nofal E, Farag F, Nofal A, Eldesouky F, Alkot R, Abdelkhalik Z (2016) Gabapentin: a promising therapy for uremic pruritus in hemodialysis patients: a randomized-controlled trial and review of literature. J Dermatolog Treat 27:515–519. https://doi.org/10.3109/09546634.2016.1161161

    Article  CAS  PubMed  Google Scholar 

  69. Pour-Reza-Gholi F, Nasrollahi A, Firouzan A, Nasli Esfahani E, Farrokhi F (2007) Low-dose doxepin for treatment of pruritus in patients on hemodialysis. Iran J Kidney Dis 1:34–37

    PubMed  Google Scholar 

  70. Foroutan N, Etminan A, Nikvarz N, Shojai Shahrokh Abadi M (2017) Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial. Hemodial Int 21:63–71. https://doi.org/10.1111/hdi.12455

    Article  PubMed  Google Scholar 

  71. Haber R, Bachour J, Salloum A, Maacaron T, Khoury F, Habr L, Ammoury A, Joubran N (2020) Comparison of gabapentin and doxepin in the management of uremic pruritus: a randomized crossover clinical trial. Dermatol Ther 33:e14522. https://doi.org/10.1111/dth.14522

    Article  CAS  PubMed  Google Scholar 

  72. Gholyaf M, Sheikh V, Yasrebifar F, Mohammadi Y, Mirjalili M, Mehrpooya M (2020) Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study. Int Urol Nephrol 52:1155–1165. https://doi.org/10.1007/s11255-020-02473-3

    Article  CAS  PubMed  Google Scholar 

  73. Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y (2005) Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16:3742–3747. https://doi.org/10.1681/ASN.2005020152

    Article  CAS  PubMed  Google Scholar 

  74. Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, laina A, (1996) Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 348:1552–1554. https://doi.org/10.1016/s0140-6736(96)04176-1

    Article  CAS  PubMed  Google Scholar 

  75. Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F, KALM-1 Trial Investigators (2020) A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med 382:222–232. https://doi.org/10.1056/NEJMoa1912770

    Article  CAS  PubMed  Google Scholar 

  76. Lipman ZM, Yosipovitch G (2021) An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease. Expert Opin Pharmacother 22:549–555. https://doi.org/10.1080/14656566.2020.1849142

    Article  CAS  PubMed  Google Scholar 

  77. Weiner DE, Vervloet MG, Walpen S, Schaufler T, Munera C, Menzaghi F, Wen W, Bhaduri S, Germain MJ, Investigators Trial (2022) Safety and effectiveness of difelikefalin in patients with moderate-to-severe pruritus undergoing hemodialysis: an open-label, multicenter study. Kidney Med 4:100542. https://doi.org/10.1016/j.xkme.2022.100542

    Article  PubMed  PubMed Central  Google Scholar 

  78. Simonsen E, Komenda P, Lerner B, Askin N, Bohm C, Shaw J, Tangri N, Rigatto C (2017) Treatment of uremic pruritus: a systematic review. Am J Kidney Dis 70:638–655. https://doi.org/10.1053/j.ajkd.2017.05.018

    Article  CAS  PubMed  Google Scholar 

  79. Sapam R, Waikhom R (2018) Role of narrow band ultra violet radiation as an add-on therapy in peritoneal dialysis patients with refractory uremic pruritus. World J Nephrol 7:84–89. https://doi.org/10.5527/wjn.v7.i4.84

    Article  PubMed  PubMed Central  Google Scholar 

  80. Penny JD, Salerno FR, Akbari A, McIntyre CW (2021) Pruritus: is there a grain of salty truth? Hemodial Int 25:E10–E14. https://doi.org/10.1111/hdi.12885

    Article  PubMed  Google Scholar 

  81. To TH, Clark K, Lam L, Shelby-James T, Currow DC (2012) The role of ondansetron in the management of cholestatic or uremic pruritus–a systematic review. J Pain Symptom Manage 44:725–730. https://doi.org/10.1016/j.jpainsymman.2011.11.007

    Article  CAS  PubMed  Google Scholar 

  82. Mettang T, Krumme B, Bohler J, Roeckel A (2007) Pentoxifylline as treatment for uraemic pruritus–an addition to the weak armentarium for a common clinical symptom? Nephrol Dial Transplant 22:2727–2728. https://doi.org/10.1093/ndt/gfm343

    Article  CAS  PubMed  Google Scholar 

  83. Badiee Aval S, Ravanshad Y, Azarfar A, Mehrad-Majd H, Torabi S, Ravanshad S (2018) A systematic review and meta-analysis of using acupuncture and acupressure for uremic pruritus. Iran J Kidney Dis 12:78–83

    PubMed  Google Scholar 

  84. Pakfetrat M, Basiri F, Malekmakan L, Roozbeh J (2014) Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial. J Nephrol 27:203–207. https://doi.org/10.1007/s40620-014-0039-2

    Article  CAS  PubMed  Google Scholar 

  85. Tseng CY, Wu TT, Lai CW, Lin HJ, Chou CY, Chang CT, Chen HC (2018) Vegetarian diet may ameliorate uremic pruritus in hemodialysis patients. Ren Fail 40:514–519. https://doi.org/10.1080/0886022X.2018.1512871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Kinugasa E, Igawa K, Shimada H, Kondo M, Funakoshi S, Imada N, Itami N, Fukazawa N, Takubo R, Kawata Y, Murota H (2021) Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study. Clin Exp Nephrol 25:875–884. https://doi.org/10.1007/s10157-021-02047-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Hercz D, Jiang SH, Webster AC (2020) Interventions for itch in people with advanced chronic kidney disease. Cochrane Database Syst Rev 12:CD011393. https://doi.org/10.1002/14651858.CD011393.pub2

    Article  PubMed  Google Scholar 

  88. Sukul N, Speyer E, Tu C, Bieber BA, Li Y, Lopes AA, Asahi K, Mariani L, Laville M, Rayner HC, Stengel B, Robinson BM, Pisoni RL (2019) Pruritus and patient reported outcomes in non-dialysis CKD. Clin J Am Soc Nephrol 14:673–681. https://doi.org/10.2215/CJN.09600818

    Article  PubMed  PubMed Central  Google Scholar 

  89. Ting SW, Fan PC, Lin YS, Lin MS, Lee CC, Kuo G, Chang CH (2020) Association between uremic pruritus and long-term outcomes in patients undergoing dialysis. J Am Acad Dermatol 83:924–925. https://doi.org/10.1016/j.jaad.2020.01.011

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USA

    Shweta Shah, Elizabeth Onugha & Sarah J. Swartz

Authors
  1. Shweta Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Onugha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarah J. Swartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shweta Shah.

Ethics declarations

Ethics approval

This manuscript complies with ethical standards.

Conflict of interest

Authors Shweta Shah and Elizabeth Onugha declare no conflict of interest. Sarah Swartz was the consultant/speaker for Fresenius Medical Care North America July 2021 through December 2021 to promote COVID vaccines in pediatrics.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Graphical abstract (PPTX 112 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, S., Onugha, E. & Swartz, S.J. Chronic kidney disease–associated pruritus: what is known and its application in children. Pediatr Nephrol 39, 25–35 (2024). https://doi.org/10.1007/s00467-023-05998-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-023-05998-8

Keywords

Search

Navigation